Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Telehealth and eHealth

 

Interview – Ingeborg Oie, CFO and Chief Strategy Officer, Huma 

In this wide ranging interview we discuss the future of remote patient monitoring (RPM) software and government progress in ehealth. Through its RPM platform,  Huma claims to massively cut costs and improve outcomes for patients with chronic conditions.

See the Global Top 50 by Market Cap

Who are the Global Top 50 Health Care Service Companies by market cap and what does this tell us about the industry? What is striking is how very few of the top 50 are now EMEA companies - just 13, and of those only four are headquartered in Europe, rather than the Middle East or South Africa. 

Beleaguered Babylon searches for UK buyer, closes in the US

Under fire digital health company Babylon is shutting down its US operations and looking to sell its UK business. Plans to merge with Swiss digital neurotherapy company MindMaze and be taken private by creditors have collapsed and it is now on the brink of bankruptcy.

Interview: Dr. Nadine Hachach-Haram, CEO and Founder, Proximie

HBI catches up with Dr. Nadine Hachach-Haram, the CEO and founder of global health technology platform Proximie to hear about how MedTech can improve surgical education and performance, address variations in quality of care, and bring the operating theatre into the 21st century.

75 years on: is the future of the NHS private?

The UK NHS was once globally revered, but cracks are showing as it marks seventy-five years and a question mark hangs over its future. HBI asks half a dozen experts what role for-profits have in its future - and whether it will it last another 75 years.

The fall of Babylon

Telehealth company Babylon will be merged with digital neurotherapy company MindMaze and taken private by its creditors. HBI catches up with two digital health experts to discuss what happened to Babylon and what the sorry saga means for the market.  

HBI 2023: Healthcare regulation – opportunities and risks

Regulatory changes are one of the major concerns among players in healthcare services. A busy panel of lawyers, operators and investors considered this thorny issue at HBI 2023, with a general feeling that even the strictest of regulations can provide some kind of opportunity, and that private funding is so essential a component in health care today, it cannot be legislated away.

17 things we learned at HBI 2023: Our key insights and takeaways

Our annual conference took place earlier this week in London. Over a jam-packed three days of HBI 2023, an impressive array of delegates from across Europe and beyond gathered in the heart of London and shared their insights into the myriad challenges and abundant opportunities the sector faces, and offered their views on how some of them might be addressed. Here are some of our key takeaways.

Where to look for green shoots in health care M&A

M&A in European health care has been almost at a standstill in H1 2023, as the chasm between the price expectations of buyers and sellers has grown. HBI asks if the prospects look better for H2 and beyond, with the help of market experts.

Ukraine Minister of Health Recovery to speak at HBI 2023

Ukraine has big plans to leverage the for-profit sector to rebuild its shattered health care system after the war. Oleksii Iaremenko, Head of Health Recovery at the Ukraine Ministry of Health is speaking at HBI 2023, June 19-21. Meanwhile we talk to fellow panelist Mark Hellowell, an academic at the University of Edinburgh who with the EBRD is sitting alongside Iaremenko on the Ukraine panel.

Find Us